Institutional members access full text with Ovid®

Share this article on:

Cervical Cancer Screening and Prevention in Low-resource Settings

BRADFORD, LESLIE MD; GOODMAN, ANNEKATHRYN MD

Clinical Obstetrics & Gynecology: March 2013 - Volume 56 - Issue 1 - p 76–87
doi: 10.1097/GRF.0b013e31828237ac
Screening Tests for Cervical Cancer

Cervical cancer is both preventable and curable, yet it remains one of the leading causes of mortality in women worldwide. Approximately 88% of cervical cancer cases are diagnosed in low-resource countries, yet very few resources are allocated to prevention and treatment programs. In fact, it is estimated that only 5% of women in low-resources countries are screened appropriately for cervical cancer. Cytology-based programs are not feasible because of lack of healthcare infrastructure and cost, thus alternative methods of cancer screening, such as visual inspection with acetic acid and HPV-DNA testing, have been intensively studied and are reviewed in this article.

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, Massachusetts

The authors declare that they have nothing to disclose.

Correspondence: Annekathryn Goodman, MD, Division of Gynecologic Oncology, Massachusetts General Hospital, Boston, MA 02114. E-mail: jschorge@partners.org

© 2013 Lippincott Williams & Wilkins, Inc.